21 February 2021 | by Bangkok Business Online – 1,137 – The last day! Hurry to review the right “We won” Round 1 within 21 February 2020 prepare to receive money into “Pao Tang” 11 Mar Remind each other again For registrants, “We won” and found unauthorized messages. Able to apply for rights review through … Read more
Many internet users have posted their dissatisfaction about We win After getting into the online wallet in the pocket money app, it was so difficult that the hashtag #we won and #pangtang got a lot of buzz among Twitter users in Thailand. Until ranked among the top most talked about hashtags When Thursday afternoon (Feb. … Read more
–Daewoong Pharmaceutical succeeded in winning the 1st trillion club. Photo = Economic Review Reporter Hwang Jin-joong – [이코노믹리뷰=황진중 기자] Daewoong Pharmaceutical (069620) announced on the 15th that it recorded 17 billion won in operating profit on a consolidated basis last year. This is a 62% decrease from the previous year. Last year’s sales amounted to … Read more
Efficacy evaluation of COVID-19 treatment at the National Institute of Infectious Diseases [아시아경제 김지희 기자] As of 0:00 on the 11th, 80 cases of Corona 19 mutant virus were confirmed in Korea. In particular, as concerns about the spread of the mutant virus have increased as cases of spreading to local communities have recently been … Read more
![[비즈헬스] Celltrion opens the era of’domestic Corona 19 treatment’… Conditional approval of antibody treatment’Rekirona’](https://cdn.bizwnews.com/news/thumbnail/202102/23098_23415_3515_v150.jpg "[비즈헬스] Celltrion opens the era of’domestic Corona 19 treatment’… Conditional approval of antibody treatment’Rekirona’")
–Celltrion’s’Rekironaju’ was born as the first domestic COVID-19 treatment. Photo = Celltrion – [비즈월드] Celltrion’s COVID-19 antibody treatment,’Recyronaju (ingredient name Legdanvimab)’ has opened the era of the domestic Corona 19 treatment. According to related industries and Celltrion, the Ministry of Food and Drug Safety approved the conditional product approval of Rekkirona on the afternoon of … Read more
Concerns have been raised that COVID-19 antibody therapy may not be effective against the South African mutant virus. Dave Riggs, chief executive of US pharmaceutical company Eli Lilly, said the South African mutant virus could theoretically evade its treatment. Eli Lilly’s COVID-19 antibody treatment was approved for emergency use by the US Food and Drug … Read more
![[특징주] Shinpoong Pharmaceutical, Piramax Corona 19 Global Clinical Phase 3 News’Strong’](https://www.etoday.co.kr/images/etoday_og.jpg "[특징주] Shinpoong Pharmaceutical, Piramax Corona 19 Global Clinical Phase 3 News’Strong’")
Shinpoong Pharmaceutical is strong on the news that Piramax’s COVID-19 global clinical phase 3 is underway. As of 9:28 am on the 6th, Shinpoong Pharmaceutical is trading at 124,000 won, up 6,000 won (5.06%) from the previous day. According to the FDA and an economic media in Korea, the Liverpool School of Tropical Medicine at … Read more
–CT-P59 (ingredient name regdanvimab), a novel corona 19 antibody drug developed by Celltrion. Source = Newsis – [이코노믹리뷰=황진중 기자] It is expected that Celltrion (068270) will be transferred to the Ministry of Food and Drug Safety for approval of the new Corona 19 antibody drug CT-P59 (ingredient name Regdanvimab), which is being developed by itself. … Read more
–Celltrion is producing commercially available quantities of’CT-P59′, a new corona19 antibody drug. Source = Celltrion – [이코노믹리뷰=황진중 기자] The Ministry of Food and Drug Safety emphasized that a domestic antibody treatment development company plans to apply for approval in December. The Ministry of Food and Drug Safety is undergoing a preliminary review on three vaccine … Read more